Infect Immun. 1986 Dec;54(3):635-40. doi: 10.1128/iai.54.3.635-640.1986.

Some galE mutants of Salmonella choleraesuis retain virulence.

Infection and immunity

N A Nnalue, B A Stocker

PMID: 3781619 PMCID: PMC260216 DOI: 10.1128/iai.54.3.635-640.1986
Free PMC Article

Abstract

galE mutants were isolated from three mouse-virulent strains of Salmonella choleraesuis (of group C1, O antigen 6,7) by selection for resistance to 2-deoxygalactose. The galE derivative of strain 381 comprised two components: galactose sensitive, thought to be the original mutant; and galactose resistant, presumably by a second mutation reducing galK or galT function or both. The galactose-sensitive component had an intraperitoneal 50% lethal dose for BALB/c mice of ca. 4 X 10(6) CFU, whereas the galactose-resistant component was about as virulent as its gal+ parent, with a 50% lethal dose of ca. 100 CFU. The galE mutant of strain 110 was somewhat sensitive to galactose, as shown by retardation of growth; its 50% lethal dose, ca. 500 CFU, was not much greater than the ca. 200 CFU value for its parent. The galE mutant of strain 117 showed the same partial sensitivity to galactose as strain 110 galE, but was nonvirulent (50% lethal dose of ca. 10(6) CFU versus ca. 400 CFU for its parent). Growth on galactose-supplemented medium restored the smooth phenotype, as indicated by phage sensitivity to three of the four galE strains, but only partially so for the strain 117 galE mutant. The retention of parental virulence by galE mutants of S. choleraesuis which are galactose resistant or somewhat galactose sensitive contrasts with the greatly reduced virulence of galactose-resistant galE mutants of Salmonella typhimurium and Salmonella typhi; this difference may result from the absence of galactose from the O repeat unit in the lipopolysaccharide of group C1 salmonellae.

Similar articles

References

1. J Bacteriol. 1971 Jul;107(1):155-61 - PubMed
2. J Infect Dis. 1975 May;131(5):553-8 - PubMed
3. J Bacteriol. 1961 Jun;81:863-8 - PubMed
4. J Bacteriol. 1950 Jul;60(1):17-28 - PubMed
5. Infect Immun. 1971 Sep;4(3):177-88 - PubMed
6. Infect Immun. 1970 Sep;2(3):309-15 - PubMed
7. J Bacteriol. 1975 Jan;121(1):259-66 - PubMed
8. J Infect Dis. 1977 Dec;136(6):717-23 - PubMed
9. Biochim Biophys Acta. 1961 Apr 15;48:470-83 - PubMed
10. J Infect Dis. 1982 Mar;145(3):292-5 - PubMed
11. Infect Immun. 1971 Dec;4(6):663-73 - PubMed
12. Eur J Biochem. 1980;107(1):145-53 - PubMed
13. Nucleic Acids Res. 1979 Nov 24;7(6):1513-23 - PubMed
14. Nature. 1959 Oct 10;184(Suppl 15):1168-9 - PubMed
15. Eur J Biochem. 1980;107(1):137-43 - PubMed
16. J Immunol. 1968 Feb;100(2):292-306 - PubMed
17. J Bacteriol. 1969 Oct;100(1):103-9 - PubMed
18. J Gen Microbiol. 1967 Aug;48(2):179-88 - PubMed
19. Folia Microbiol (Praha). 1968;13(5):439-49 - PubMed
20. Ann Inst Pasteur (Paris). 1968 Jul;115(1):62-7 - PubMed
21. Bull World Health Organ. 1980;58(3):469-74 - PubMed
22. J Bacteriol. 1965 Mar;89:630-9 - PubMed
23. J Bacteriol. 1952 Mar;63(3):399-406 - PubMed
24. J Gen Microbiol. 1972 May;70(3):527-54 - PubMed

Substances

• Bacterial Vaccines
• Lipopolysaccharides
• Polysaccharides, Bacterial
• Carbohydrate Epimerases
• UDPglucose 4-Epimerase
• Galactose

MeSH terms

• Animals
• Bacterial Vaccines / immunology
• Carbohydrate Epimerases / genetics
• Galactose / metabolism
• Genes, Bacterial
• Lipopolysaccharides / physiology
• Mice
• Mutation
• Polysaccharides, Bacterial / physiology
• Salmonella / genetics
• Salmonella / pathogenicity
• UDPglucose 4-Epimerase / genetics

Publication Types

• Journal Article

LinkOut - more resources

• Full Text Sources
  • Atypon
  • Europe PubMed Central
  • PubMed Central
• Miscellaneous
  • NCI CPTAC Assay Portal
• Other Literature Sources
  • The Lens - Patent Citations